Safety Outcomes
ADVERSE EVENTS
The GDLM group and the placebo group had a similar incidence of adverse events (303 [17.6%] vs 298 [17.3%]; risk difference, −0.27%; 95% CI, −2.26%-2.80%; OR, 1.02; 95% CI, 0.85-1.21; RR, 1.02; 95% CI, 0.88-1.17; 